BIOiSIM

BIOiSIM

VERISIMLife
Gritstone

Gritstone

Gritstone bio
+
+

Related Products

  • Azore CFD
    24 Ratings
    Visit Website
  • StackAI
    49 Ratings
    Visit Website
  • FrameworkLTC
    48 Ratings
    Visit Website
  • BLAZE
    6 Ratings
    Visit Website
  • Revaly
    7 Ratings
    Visit Website
  • NovusMED
    1 Rating
    Visit Website
  • Aesthetic Insight
    8 Ratings
    Visit Website
  • Elation Health
    86 Ratings
    Visit Website
  • Eldermark
    40 Ratings
    Visit Website
  • LM-Kit.NET
    24 Ratings
    Visit Website

About

BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses. Our models are built on data from thousands of compounds across 7 species, leading to robustness rarely seen in the industry. With a focus on human outcomes, the platform has at its core a translatability engine that transforms insights across species. The BIOiSIMTM platform can be used before the preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation.

About

The first pillar of our immunotherapy is our understanding of antigens and neoantigens, and specifically which ones will be transcribed, translated, processed and presented on a cell surface by Human leukocyte antigen (HLA) molecules; and therefore will be visible to T cells. We accomplish this through the use of Gritstone EDGETM, our proprietary machine learning-based platform. Developing cancer immunotherapies that include tumor-specific neoantigens presents a challenge due to their nature – tumors typically have hundreds of mutations, but only a small percentage of those mutations result in true tumor-specific neoantigens that are. To address this challenge, we trained EDGE’s novel integrated neural network model architecture with millions of data points from hundreds of tumor and normal tissue samples from patients of various ancestries.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Labs and companies in the drug development industry searching for a virtual drug development engine

Audience

Anyone looking for a scientific platform that helps with accurate identification of antigens

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

VERISIMLife
United States
www.verisimlife.com/our-platform/

Company Information

Gritstone bio
Founded: 2015
United States
gritstonebio.com/scientific-platform/

Alternatives

Alternatives

MIStar

MIStar

Apollo Medical Imaging Technology
MIRIO

MIRIO

DEEPLINK MEDICAL

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim BIOiSIM and update features and information
Claim BIOiSIM and update features and information
Claim Gritstone and update features and information
Claim Gritstone and update features and information